medacta
-
Recon
Medacta Announces the Launch of GMK SpheriKA, the World’s First Knee Implant Optimized for Kinematic Alignment (KA)
Castel San Pietro, October 30, 2023 – Medacta Group S.A. (‘Medacta,’ SIX: MOVE), a Swiss company featuring innovative, personalized, and…
Read More » -
Spine
New clinical study demonstrates Medacta’s MySpine accuracy in screw replacement during spine revision surgery
CASTEL SAN PIETRO, 20 March 2023 – Medacta Group SA (“Medacta”, SIX:MOVE), a Swiss company specializing in the design, production,…
Read More » -
Recon
Geisinger, Medacta partner to be first in the world to guarantee patient outcomes for knee, hip and shoulder replacement surgeries
CASTEL SAN PIETRO, Switzerland and DANVILLE, Pa. August 23, 2021 – Going for a joint replacement surgery is a major decision…
Read More » -
Recon
Medacta Announces Successful Completion of First Reverse Shoulder Arthroplasties using NextAR Augmented Reality Surgical Platform
Game-changing innovation allowed surgeons to precisely replicate preoperative planning, while maintaining closer focus on their patients for improved accuracy and…
Read More » -
Spine
Medacta Announces First U.S. Surgery with the New M.U.S.T. LT System in Minimally Invasive Spine Surgery
Media release CASTEL SAN PIETRO, 28 April 2021 – Medacta announced today the first surgery utilizing its M.U.S.T.(R) LT, following clearance by the…
Read More » -
Financial
Medacta Group SA continues to outperform the market with a strong revenue acceleration in the second semester 2020
Press Release – 2020 Preliminary unaudited top-line figures • FY 2020 revenues were €302.5 million, only -2.1% on a constant…
Read More » -
Recon
Medacta to Introduce NextAR(TM): First FDA-Cleared Augmented Reality-Based Surgical Platform for Total Knee Replacement
CASTEL SAN PIETRO, 13 July 2020 – Medacta today announced it has received clearance from the U.S. Food and Drug Administration…
Read More » -
Spine
Medacta : Announces First Surgery Utilizing Mecta-C Stand Alone Anterior Cervical Interbody Fusion Device and New Registrations
Media Release CASTEL SAN PIETRO, 28 May 2020 – Medacta announced today the first surgery utilizing its recently FDA-cleared Mecta-C Stand Alone…
Read More »